The MTSC is connecting academia, industry, and investment capital to turn MedTech ideas into commercial realities.
Funded by Research England, the MedTech SuperConnector is an Imperial College-led initiative from a consortium of eight dynamic London universities with interest in nurturing talent, ideas, and entrepreneurship. MTSC focuses uniquely on a new route for early career researchers (ECRs) and graduate students to translate MedTech discoveries from academic labs into startup companies, proposing new solutions to today’s health challenges.
Four cohorts of ECRs are being taken through an eight-month entrepreneurial training programme. In addition to expert business mentoring and training, they have funding and access to state-of-the-art facilities and expertise across the eight institutions. Through the SuperConnector they also have the opportunity to create connections with industry partners and potential investors to bring their projects to market.
Following a competitive call for applicants, the first cohort of 10 innovators includes two CPS ECRs. Letizia Gionfrida is using artificial intelligence and motion analysis to improve the diagnosis of musculoskeletal disorders, and George Waddell is developing an online platform to enhance clinical communication training.